Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.

作者信息

Beumont P, Bruwer J, Pimstone B, Vinik A, Utian W

出版信息

Br J Psychiatry. 1975 Mar;126:285-8. doi: 10.1192/bjp.126.3.285.

DOI:10.1192/bjp.126.3.285

PMID:236061

Abstract

摘要

相似文献

Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.

Br J Psychiatry. 1975 Mar;126:285-8. doi: 10.1192/bjp.126.3.285.

Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).

Am J Obstet Gynecol. 1975 May 1;122(1):85-9. doi: 10.1016/0002-9378(75)90618-3.

Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.

Acta Endocrinol (Copenh). 1975 May;79(1):25-33. doi: 10.1530/acta.0.0790025.

Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.

Obstet Gynecol. 1976 Jul;48(1):84-9.

Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Br Med J. 1972 Sep 16;3(5828):669-72. doi: 10.1136/bmj.3.5828.669.

Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.

J Clin Endocrinol Metab. 1974 Jul;39(1):18-26. doi: 10.1210/jcem-39-1-18.

Bromocryptine therapy in cases of amenorrhea-galactorrhea.

Am J Obstet Gynecol. 1977 Feb 1;127(3):291-8. doi: 10.1016/0002-9378(77)90472-0.

Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.

Obstet Gynecol. 1975 Jul;46(1):1-11. doi: 10.1097/00006250-197507000-00001.

Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.

Am J Obstet Gynecol. 1975 Feb 1;121(3):375-9. doi: 10.1016/0002-9378(75)90015-0.

[The role of prolactin in disturbances of the menstrual cycle].

Gynecologie. 1974;25(2):229-31.

引用本文的文献

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?

Endocr Oncol. 2022 Apr 21;2(1):R31-R50. doi: 10.1530/EO-21-0038. eCollection 2022 Jan.

Drugs and prolactin.

Pituitary. 2008;11(2):209-18. doi: 10.1007/s11102-008-0106-6.

A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia.

Sao Paulo Med J. 2006 Sep 7;124(5):291-7. doi: 10.1590/s1516-31802006000500012.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Drugs. 2004;64(20):2291-314. doi: 10.2165/00003495-200464200-00003.

Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.

J Endocrinol Invest. 2000 Dec;23(11):765-70. doi: 10.1007/BF03345068.

Bromocriptine and psychosis: a literature review.

Psychiatr Q. 1995 Spring;66(1):87-95. doi: 10.1007/BF02238717.

Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.

J Neural Transm. 1985;62(3-4):219-30. doi: 10.1007/BF01252238.

Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Drugs. 1979 May;17(5):337-48. doi: 10.2165/00003495-197917050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验